The Effect of Increased Numbers of Carcinogenic Treatments on the Induction of Cervico-Vaginal and Vulval Tumours in Intact and Castrate Rats by Glucksmann, A. & Cherry, Cora P.
333
THE EFFECT OF INCREASED NUMBERS OF CARCINOGENIC
TREATMENTS ON THE INDUCTION OF CERVICO-VAGINAL
AND VULVAL TUMOURS IN INTACT AND CASTRATE RATS
A. GLUJCKSMANN* AND CORA P. CHERRYt
From the Strangeways Research Laboratory, Cambridge
Received for publication January 30, 1970
SUMMARY.-The effect of 5, 10, 20 or 40 weekly local applications of DMBA
on the induction of cervico-vaginal epithelial and sarcomatous tumours and
on that of squamous celled vulval neoplasms was investigated in intact and
castrate rats. The threshold dose increases in the following order: epithelial
cervico-vaginal tumours of castrates, followed by those in intacts and by
squamous celled vulval tumours and lastly by sarcomas in castrates and
intacts.
The incidence of sarcomas levels off at about 25% after 20 doses in spayed
rats, but increases to 70% with dose in intacts. All sarcomas appear between
200 and 400 days. The incidence ofvulval neoplasms increases and the duration
of the induction period decreases with dose.
Significantly more cervico-vaginal epithelial tumours occur with 5 to 20
paintings than with further applications of DMBA. Their peak value is 60%
ip castrates and 20% in intacts. Castration promotes the progression of vulval
popillomas to carcinomas. The sensitivity to carcinogenic stimulation is thus
tissue specific and also subject to modification by hormones.
While epithelial tumours are multifocal and pass through well-defined
intermediate stages (radication, papillomas, microcarcinomas) to full malig-
nancy, the early stages of sarcoma formation arerarely detected and ill-defined.
For epitheliomas and sarcomas invasion
9 is a criterion of malignancy only
if invading cells have acquired "xenoplasia ", i.e. the ability to grow in new
environments. This capacity increases progressively and its initial lack
accounts for the discrepancy between the incidence of embolism and that of
metastatic deposits.
MIcE have been used extensively and rats infrequently for the induction of
cervico-vaginal tumours by the local application ofchemical carcinogens. Strains
of mice differ in susceptibility (Kaslaris and Jull, 1962; Thiery, 1963; Thiery and
van Gijsegem, 1965) and results vary with the chemical used and the technique
ofapplication. Thus for methylcholanthrene the thread method is more effective
than painting of the genital tract (Murphy, 1961) while the reverse is true for
benzopyrene, especially when the painting is done visually (Thiery, 1963).
There are contradictory reports on the effect of castration on experimental
carcinogenesis which can be explained to some extent by differences in the period
of observation. Thus in mice castration appears to enhance and accelerate the
process (Krieg and Reagan, 1961; Islam and Zaman, 1965; Laffargue, Samso,
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Luscan and Francois, 1965; Taki, 1967; Alauddin and Zaman, 1967; Mueenuddin
and Zaman, 1967) in short term experiments with limited exposure to the carcin-
ogen. With prolonged carcinogenic exposure Murphy (1961) and Glucksmann
and Cherry (1962) found no effect of castration on tumour incidence in mice
while Meisels (1966) reported an inhibitory action. The age of animals at ovariec-
tomy is significant since castrate adult mice are less susceptible to tumour induc-
tion than those spayed when immature (Kaslaris and Jull, 1962). In rats,
castration significantly reduces the incidence of cervico-vaginal sarcomas
(Glucksmann and Cherry, 1958).
The effects of combining oestrogen administration with that of chemical
carcinogens vary with the dose of the hormone, the length of the exposure period
to the carcinogen and the species used. In mice, prolonged exposure and fairly
high doses of oestrogens given to intact and castrate animals have no effect on
carcinogenesis (Murphy 1961; Klavins and Kaufman, 1962; Laffargue et al., 1965;
Blanzat, Hirai and Pincus, 1966). Meisels (1966) reports that high doses promote
tumour formation in intact mice while low or physiological levels inhibit it in
both intact and castrate animals. After limited carcinogenic exposure ofcastrates,
subsequent treatment with diethylstilboestrol pellets enhances and accelerates
tumour formation and this effect is more marked with high than with low doses of
hormone (Murphy, 1961). In rats, oestrogens in doses sufficient to restore to
normal the castrate uterus fail to promote the induction of vaginal sarcomas in
castrates and even inhibit it in intact animals. Smaller doses insufficient to
counteract the uterine atrophy, increase and accelerate the formation of sarcomas
and of epithelial tumours of the cervico-vaginal tract in castrates but have no
effect in intacts (Glucksmann and Cherry, 1968). The different effects of oestro-
gens on tumour induction in mice and rats may be due to dissimilar sensitivities
to this hormone in the two species and for mice it has been shown that different
strains vary in their response to oestrogens (Gardner, 1953; Murphy, 1961).
The use of cholesterol as carrier for oestrogen in pellets complicates the issue
since by itself it increases the formation of sarcomas and epithelial tumours in
spayed rats (Glucksmann and Cherry, 1968) and in castrate mice treated and
observed for only 5 weeks (Taki, 1967). Septic pyometra caused by high doses
of oestrogens may promote tumour formation in mice (Gardner, 1953; Murphy,
1961) though in rats have a slightly inhibitory effect (Glucksmann and Cherry,
1968).
The histological type of induced tumour also differs in the two species. In
mice most of the tumours have been carcinomas though some carcinogens have
induced sarcomas (Murphy, 1961; Kaslaris and Jull, 1962; Meisels, 1964, 1966).
While the majority of the carcinomas have been of the squamous cell type, some
mucoepidermoid cancers have been reported (Murphy, 1961; Barbieri, Olivi and
Paoletti, 1961; Thiery and van Gijsegem, 1965; Taki, 1967) and their incidence is
increased by castration with or without additional treatment with progesterone
(Glucksmann and Cherry, 1962). In Murphy's experiments all mixed carcinomas
occur in castrate mice and none in intact animals or in castrates given additional
oestrogens. Similarly Klavins and Kaufman (1962) report more highly differ-
entiated squamous celled cancers in intact mice treated with oestrogen in combina-
tion with methylcholanthrene threads. In rats with DMBA-impregnated threads
in the endocervical canal, the tumours induced are mainly carcinomas including
one adenoacanthoma (Vellios and Griffin, 1957).
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A carcinogen-impregnated thread inserted into the endocervical canal may be
expected to induce more mixed carcinomas than painting the exocervix and
vagina of mice because of the differences in histology though under certain
conditions (Murphy, 1961; Glucksmann and Cherry, 1962) mucoepidermoid
cancers occur after painting the cervix and vagina. The mucifying effect on the
cervico-vaginal epithelium of castration and progesterone are probably responsible
for the induction ofmixed carcinomas.
There is a species predisposition for carcinomas in mice and for sarcomas in
rats following intravaginal painting. However, sarcomas occur in some mice and
in intact and castrate rats epithelial tumours are induced by additional treatment
with testosterone (Glucksmann and Cherry, 1968). Low doses of stilboestrol
or cholesterol pellets in castrates increase the incidence of sarcomas and of
epitheliomas.
In rats painted weekly with carcinogens the induction period for tumours is
very long and it is feasible that some of the carcinogenic insults are wasted.
Differences in carcinogenic dosage may account for some of the conflicting results
obtained with castration and for the histological type of the induced tumours,
i.e. whether epithelial or sarcomatous. In the present experiments the effect
of 5,10, 20 and nominally 40 weekly intravaginal applications ofDMBA have been
investigated in intact as well as castrate rats.
MATERIALS AND METHODS
Hooded rats of the Lister strain random bred within a closed colony since
1940 were used for the experiments which extended over a period from 1955 to
1967. The rats were housed 7 to a cage and given water and food pellets of
MRC-diet 86 ad libitum. Only animals surviving for at least 120 days after
starting the experiment were considered at risk. The number of animals in the
various treatment groups are given in Table I.
Bilateral ovariectomy was performed with a dorsal approach under ether
anaesthesia on rats aged 4 to 5 weeks. Carcinogenic treatment with a 1%
solution in acetone of 9,10-dimethyl-1,2-benzanthracene (DMBA, Koch-Light
Ltd.) was started when intact and castrate animals were 2 months old. The
vagina was stretched open by dorsal flexion of the tail and, by means of a cotton
wool swab mounted on a thin wire rod, the solution was distributed by a rotary
motion over the cervix, vagina and introitus at weekly intervals either for the
life span of the animals (with an average of 40 applications) or restricted to 5,
10 or 20 times (Table I).
TABLE I.-Number ofAnimals at riskforDifferent Numbers of Weekly
Applications of DMBA
DMBA Intact rats Castrate rats
x 5 20 . 22
xl1 20 . 22
x 20 21 . 46
x 40 43 36
Some of the experiments were repeated after intervals of 2 to 10 years, and
gave almost identical figures for the induction of tumours. In intact rats treated
for an average of 40 weeks the repeat experimerit was done after an interval of
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6 years and in similarly treated castrates the time lapse was 10 years, while in
castrates given 20 applications of DMBA the interval between the experiments
was 2 years. For purposes of comparison, the results in the two intact groups
were combined and the same was done for the castrates. This accounts for the
larger number of animals at risk in three of the experimental groups (Table I).
The rats were examined at weekly intervals and sick animals or those with
clinical signs ofvaginal orvulval tumours werekilledandapost-mortem performed.
In addition to the organs of the genital tract from ovary to vulva the following
tissues were fixed for histological examination: pituitary, thyroid, thymus, lungs,
liver, spleen, kidneys, adrenals, intestine, mesenteric, lumbar and inguinal nodes.
The material was fixed in Zenker-acetic or Bouin's fluid, dehydrated, embedded in
paraffin and sectioned at 6 or 8 ,t depending on the organ. The endocrine glands
and, when necessary, the cervix and vagina were sectioned serially. Sections
were stained with haematoxylin-eosin, Van Gieson, carmalum-orange G-aniline
blue, Southgate's mucicarmine or the periodic acid-Schiff technique (PAS) after
diastase digestion.
Calculation ofResults
For the age-specific induction rates the number of tumour-bearing animals
amongst those at risk for consecutive 100 day periods was plotted at the 50 day
interval. The number of tumours in individual animals could not be assessed
accurately since papillomas and carcinomas had a multifocal origin and later
became confluent. The most advanced lesion was the criterion used in the
classification of tumour-bearing rats. If animals had two distinct types of neo-
plasms they were included separately under sarcomas and epithelial tumours.
Histogenesis ofEpithelial Tumours
Carcinogenesis in the cervico-vaginal epithelium is similar in intact and castrate
rats although the rate of progression is modified by hormonal status and dosage
ofDMBA. Marked dysplasia and carcinoma in situ with characteristic abnormal
changes in nuclei and maturation of epithelial cells (Fig. 1) are seen only rarely.
The initial lesion is hyperplasia of the epithelium with radication, i.e. finger-like
downgrowths of epithelium into the underlying connective tissue (Fig. 2). This
change may be localized or involve a considerable extent of the epithelium. The
projections have an intact basement membrane and their cells show uniformity
as regards their volume and nuclear size in their respective layers, orderly strati-
fication and squamous differentiation of the superficial cells (Fig. 3).
Further proliferation leads to the formation of extruding or intruding papil-
lomas. Extruding papillomas present as papilliform projections from the surface
of the epithellum with a central core of vascularized stroma derived from the
lamina propria (Fig. 4) though it is less dense and has finer fibres than the normal
subepithelial connective tissue. The epithelial cells of extruding papillomas
show few, if any, cytological abnormalities, good stratification and normal
differentiation. However, as compared with radication, the relative proportion
of basal to keratinizing cells may be increased.
Intruding papillomas may arise directly in radications or at the base of extru-
ding lesions. The radices become confluent and grow downwards (Fig. 5) into
the subepithelial connective tissue which is reduced to a thin fibrillar stroma.
Cytologically intruding papillomas resemble extruding ones as regards cell and
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nuclear size, stratification and maturation of cells though mitotic activity may be
greater in the basal cells which may also form a relatively larger proportion of the
total cell population (Fig. 6). In both forms of warts the basement membrane
of the epithelial formations is intact and there is little inflammatory cell reaction
in the stroma.
The absence of a basement membrane and keratinization at the tips of the
epithelial projections characterize the development of microcarcinomas. The
basal cells are thus exposed to the strange environment of the underlying stroma
and still lack the ability to survive and proliferate in a " xenotopic " environment.
At this stage in tumour progression these invading incipient cancer cells have not
acquired the property of xenoplasia. As a result these epithelial cells enlarge and
attempt cornification with an increased amount of condensed cytoplasm and
eventually they differentiate or degenerate. This process leads to a reversal of
the structure of the epithelial foci which have keratinizing cells in the foremost
part (Fig. 7) instead of at the centre (Fig. 3, 4 and 6). Variation in the size of
cells and their nuclei, hyperchromatosis, frequent and often abnormal mitoses,
irregular stratification and abnormal differentiation mark the carcinomatous
progress of this stage. The surrounding stroma may contain an inflammatory
cell reaction with foreign body giant cells especially around exfoliated keratinized
ordegenerate cells.
The final stage is a fully developed autonomous carcinoma in whichtheinvading
cancer cells are adapted for growth in a xenotopic environment and survive and
proliferate in the stroma without the protection of a basement membrane. The
invading tumour foci exhibit the characteristic cytological changes associated with
malignancy (Fig. 8). The tumours vary in the degree of anaplasia of their cells
and while many are well differentiated keratinizing squamous cell carcinomas,
others are very anaplastic and produce at best only scattered parakeratotic cells.
In the present experiments only squamous cell tumours have been induced in
both intact and castrate rats and special staining with PAS and mucicarmine has
failed to reveal any mixed carcinomas with columnar as well as squamous
components.
The tumours spread by direct extension in the subepithelial connective tissues,
latertheypenetrate the inner smoothmusclelayerofthe vagina, extend throughout
the thickness of the vaginal wall and involve the rectum or paravaginal tissues.
Extension also occurs by growth in the perineural lymphatics (Fig. 9) and although
emboli are seen not infrequently in the lymphatics (Fig. 10) and even blood vessels
at the periphery of the tumours, lymph node and lung metastases are found very
rarely.
Contamination of the vulva by DMBA painting of the cervico-vaginal tract
induces basal cell as well as squamous cell tumours at this site. The basal cell
tumours arise from hair follicles and will not be discussed in this paper; the
squamous cell types are included only for comparison with the cervico-vaginal
epithelial tumours. Carcinogenesis is similar to that in the vagina: carcinoma
in situ is seen very rarely in the vulval epithelium and the initial lesion is hyper-
plasia of the interfollicular epidermis which progresses through radication to the
formation of extruding and intruding papillomas, later of microcarcinomas and
finally of invasive squamous celled carcinomas.
In the vulva the panniculus carnosus is not a continuous sheet and normal
hair follicles in anagen extend beyond the level of the muscle layer. Thus the
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diagnosis ofmalignant epithelial tumours cannot be based on the penetration ofthe
panniculus carnosus and rests on the ability of the invading cells for sustained
growth in a xenotopic environment. Foci with the usual features of malignancy
are considered as evidence for autonomous carcinomas whether or not they have
penetrated the panniculus carnosus. Apart from direct extension, carcinomas of
the vulva spread by growth in the perineural and other lymphatic vessels but as
with malignant epithelial tumours of the vagina lymph node and lung metastases
are seen very rarely.
In the vagina and in the vulva papillomas and carcinomas often co-exist and
in an individual animal the most advanced lesion present has been the criterion
used for classification. In the analysis offactors modifying carcinogenesis, animals
with radication as the only lesion have been neglected. No distinction has been
made between extruding and intruding papillomas and rats with microcarcinomas
as the most advanced stage have been included in this group. Similarly the term
carcinoma includes all invasive autonomous tumours irrespective of whether they
are confined to the lamina propria or dermis or have penetrated the muscle layer.
Histogenesis ofSarcomas
DMBA painting induces tumours in the subepithelial connective tissue of the
vagina which present as cellular sarcomas, fibrosarcomas, leiomyosarcomas,
myxosarcomas, rhabdomyosarcomas or mixtures of the various components.
Giant mono- and multinucleate cells occur frequently. These neoplasms extend
through the width of the vagina, into the cervix, into the vulval region and may
involve the paravaginal tissues. They spread along the perineural lymphatics
as well as by direct extension. They also invade the overlying epithelia causing
ulcerations. Lymphatic permeation and emboli are found greatly in excess of
lymph node and distant matastases.
The earliest lesions are formed by collections of abnormally enlarged cells in
the tunica propria of the vagina either close to the epithelium or to the smooth
muscle. These cells appear abnormal and resemble those of frank sarcomas
(Glucksmann and Cherry, 1958), but initially show little proliferative activity.
Since such lesions are seen only rarely, it is likely that they are of short duration
EXPLANATION OF PLATES
FIG. 1. Carcinoma in situ in the vaginal epithelium of a castrate rat 18 months after the first
of 10 weekly applications of DMBA. Note the abnormal nuclei, the mitosis in the super-
ficial layer and the irregular stratification. H. and E. x 565.
FIG. 2 and 3. Radication of the cervico-vaginal epithelium of a castrate rat 20 months after
the first of 10 weekly applications of DMBA. The stratification and differentiation of cells
and their nuclei are normal with keratinization in the centre of the radices. H. and E.
x 140 and x 335.
FIG. 4. Extruding papilloma in the vagina of the same rat as seen in Fig. 2. The papilliform
projections have a central core of connective tissue and show regular stratification and
maturation of epithelial cells and keratinization in the central region. H. and E. x 60.
FIG. 5 and 6. Intruding papilloma in the vagina of a castrate rat 10 months after starting
DMBA treatment, i.e. after 44 applications. There is marked mitotic activity in the basal
cells, normal stratification and maturation in the other layers with differentiating cells in the
central parts of the projections. H. and E. x 30 and x 295.
FIG. 7. Microcarcinoma in the vagina of a castrate rat 18 months after the first of 10 weekly
applications of DMBA. Note the absence of the basement membrane and the enlarged and
keratinizing cells (a). Cells in the stroma (b) keratinize or degenerate. H. and E. x 300.
FIG 8, 9 and 10. Squamous-celled carcinoma of the vagina in a castrate rat 22 months after
the first of 10 weekly applications of DMBA. The tumour penetrates the muscle (Fig. 8),
spreads along the perineural lymphatics (Fig. 9) and forms emboli in vessels (Fig. 10).
H. and E. x 230, x 150 and x 425.
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and that sarcoma formation once started, progresses rapidly unlike the epithelial
neoplasms which pass through the stage of papillomatous growth and micro-
carcinomas. The variety of cellular components in many of the sarcomas may
indicate that they are due to a confluence of malignant cells with different capaci-
ties for differentiation and are thus of multicellular if not of multifocal origin.
The same picture may arise, however, if after proliferation of a single malignant
cell, clones of cells with different potentialities are formed and separated. There
is at present not sufficient evidence to decide between these possibilities.
Since even the earliest accumulations of sarcomatous cells occur within the
connective tissue and diagnosis of malignancy rests on cytological features and
particularly on proliferative activity, " invasion " is not as significant a criterion
in the diagnosis of sarcomas as it is in that of carcinomas. Invasion implies
movement into a territory outside that of origin and in the instance of cervico-
vaginal sarcomas would mean into the muscle layer or the epithelium. Malignant
tumours at these sites may extend within the tunica propria to the cervical region
or may grow along perineural lymphatics and invade the ganglia of the cervix.
In these instances permeation of lymphatics may be taken as " invasion ".
Since the presarcomatous lesions are rare and their significance and subsequent
fate doubtful, they have not been included in the quantitative analysis. Fibro-
matous thickenings are also found on rare occasions and these again have been
omitted from analysis. The histological types of sarcomas are not correlated in
their frequency with the hormonal status of the animal nor with the carcinogenic
dosage, though these factors influence the incidence and rate of tumour induction.
No primary sarcomas ofthe vulva have been elicited in the present series ofexperi-
ments and these tumours are obtained only rarely at this site (Glucksmann, 1963).
80
Intact Rats
60 Castrate Rats
40
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5 10 20 40
Weekly Applications of D M B A
FIG. 11.-Dose-response curve (with S.E.) for the induction of cervico-vaginal sarcomas
in intact and castrate rats.
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The Influence of Castration and of Variation in Number of DJIBA
Applications on Tumour Induction
(A) Cervico-vaginal sarcomas
No sarcomas are induced in intact or castrate rats by 5 paintings with DMBA
in 4 weeks (Fig. 11) and none in intact animals with 10 applications, while
14% + 7*4 appear in castrates. At this level the difference between intacts and
castrates may not be significant. In both groups of rats significantly more
sarcomas occur after 20 paintings and the difference between the two groups is not
significant (18 + 11-1). In spayed females 40 applications do not increase
tumour incidence, but in intact animals do so significantly producing a very
marked difference between the two sets (47 + 10.4). A threshold dose ofbetween
5 and 10 paintings is thus needed for the induction of sarcomas. Above 20
applications the incidence in castrates levels off, while it increases steeply in intact
animals.
The first sarcomas appear at about 200 days in most experiments and at 300
days in intact rats given 20 paintings (Fig. 12). No tumours arise after about 400
days and within that period the rate of induction is greatest for the intact rats
painted 40 times. An age-specific plot (Fig. 13) shows a peak of about 10% for
10 applications to spayed animals, of about 25% for 20 applications to either
group; for 40 doses it stays at the same level in castrates but rises to about 800%
in intacts.
There is thus a threshold dose for induction of sarcomas, a levelling off in
castrates at 20 doses, but a steep increase with dose for intact rats. No tumours
appear after about 400 days.
80
60
- Intact Rats
Castrate Rats
'40 /x2 0~~~~~~~~~~~~~V
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200 400 x 5 600 x1o 800
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Fic. 12. The induction ofcervico-vaginal sarcomas in intact and castrate rats by 40, 20,
10 or 5 weekly applications of DMBA.
340CERVICO-VAGINAL AND VULVAL TUMOURS IN RATS 341
Intact Rats
Castrate Rats
150 350 550 750
Days
FIG. 13.-Age-specific induction rates of cervico-vaginal sarcomas in intact and castrate
rats by 40, 20, 10 or 5 weekly applications of DMBA.
- Castrate Rats
10 20
Weekly Applications of 0 M B A
40
FIG. 14.-Dose-response curve (with S.E.) for the induction of cervico-vaginal carcinomas +
papillomas in intact and castrate rats.
80
60
CD
u 40
20
t=
- 40A. GLUCKSMANN AND CORA P. CHERRY
CL
- Intact Rats
- Castrate Rats
Days
FIG. 15.-The induction of cervico-vaginal carcinomas + papillomas in intact and castrate
rats by 40, 20, 10 or 5 weekly applications of DMBA.
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FIG. 16.-Age-specific induction rates of cervico-vaginal carcinomas + papillomas in intact
and castrate rats by 40, 20, 10 or 5 weekly applications of DMBA.
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(B) Cervico-vaginal carcinomas and papillomsu
The dose-response curve (Fig. 14) shows that the threshold dose for the
induction of epithelial tumours is well below 5 applications particularly for
castrates. Alevel ofabout 60% is maintained inthis group for 10 and 20paintings
and one of about 20% in intact animals. The absence of tumours in the intact
rats given 10 doses may be due to sampling. The incidence ofepithelial tumours
falls drastically in both groups if the number of doses is increased to 40 and in
castrates the fall is highly significant (59 ± 8.5). With lower numbers of paint-
ings there is a significant difference between castrates and intacts but not for
40 doses.
80
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Q 40
a,~~~~~ C, 20
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FIG. 17.-Age-specific induction rates of cervico-vaginal carcinomas and of papillomas
in castrate rats by weekly applications of DMBA.
Therate ofdevelopment ofepithelialtumours in castrates given 5, 10or20doses
is much faster than in all other groups (Fig. 15). The induction time for the first
tumours shows no correlation with either dose or ovarian status of the animals.
The age-specific peak incidence of tumours (Fig. 16) is delayed by decreasing the
number ofapplications from 20 to 5 in castrates and less so in intacts. At 20 doses
the difference in timing and height of the peak incidence between castrates and
intacts is particularly striking. The incidence of epithelial tumours is highest at
about 350 days in animals painted 40 or more times, but is only one-fourth of
that in spayed females painted 20 times.
If papillomas precede carcinomas in carcinogenesis, an earlier peak might be
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expected for rats with papillomas only than for those with carcinomas plus
papillomas. This is indeed the case (Fig. 17 and 18); irrespective of dose the
age-specific peak for papillomas in castrates and intacts occurs 100 to 200 days
before that of carcinomas. As not all papillomas turn into carcinomas, some rats
with only papillomas are found even at the peak time for carcinomas (Fig. 17).
For all groups the proportionofpapillomas to carcinomasdoes not vary consistently
or significantly with dose.
For epithelial tumours the threshold for induction lies well below 5 paintings;
the yield remains at the same level up to 20 doses and in castrates is about 3 times
80
60
Carcinomas
= 40 Papillomas
20
150 350 550 750
Days
FIG. 18.--Age-specific induction rates of cervico-vaginal carcinomas and of papillomas in
intact rats by weekly applications of DMBA.
that in intacts and with a much faster rate ofinduction. With 40 doses the percen-
tage of tumours is equal in intacts and castrates and only one-seventh of that at
lower doses. The age-specific peak for animals bearing only papillomas precedes
that for those with carcinomas.
(C) Squamous-celled vulval tumours
The threshold for the induction of these tumours lies below 5 applications and
approximately the same number are elicited inthe same time by 5 and 10 paintings.
With increasing number ofpaintings the incidence increases sharply and the time of
development is shortened in castrates and intact rats (Fig. 19 and 20).
The lengthening ofthe induction period and the decreased incidence oftumours
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with reduced numbers of doses in intacts and castrates is clearly indicated in the
age-specific plots (Fig. 21 and 22).
The proportion of carcinomas relative to papillomas increases with increasing
doses (Table II) and as in the cervico-vaginal epithelial tumours the peak inci-
dence for papillomas tends to precede that of carcinomas.
CL
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FiG. 19.-Cumulative incidence of squamous-celled vulval tumours
after 40, 20, 10 or 5 weekly applications of DMBA.
in castrate rats
TABLE II.-Squamou8-celled Tumours of the Vulva in Intact and
Castrate Rats
Intact rats
A
Carcinomas Papillomas
(%) (%)
0 20±8-9
0 24±9-3
.52+10-9 33+10-3
.63+7-4 30+7-0
Castrate rats
Carcinomas Papillomas
(%) (%)
14±7-4 5±4-6
9+6-1 9±6-1
46±7-3 33+6-9
80+6-7 11+5-2
The only clear evidence of an effect of castration on the induction of vulval
tumours is the higher proportion ofcarcinomas in castrates at the lower dose levels
(Table II). For the same total incidence of epithelial tumours, i.e. around 20%,
31
DMBA
x5
x 10
x 20
x 40
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none are carcinomas in intacts after 10 and 5 applications, whereas 50% and more
are in spayed animals. Thus progression of epithelial vulval tumours to the
carcinomatous state appears to be faster than in intact rats.
In the vulva no sarcomas are induced. The threshold dose for epithelial
tumours lies below 5 applications, the incidence of tumours increases and the
duration of the induction period decreases with increasing numbers of paintings.
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FIG. 20.-Cumulative incidence of squamous-celled vulval tumours in intact rats after
40, 20, 10 or 5 weekly applications of DMBA.
DISCUSSION
The present experiments have been designed to test the reaction to variations
in carcinogenic stimulation and to castration in different tissues, i.e. the mucous
epithelium of the cervico-vaginal tract, the epidermis of the vulval region, the
dermis of the vulva and the tunica propria of the vagina and cervix. The types
of ensuing tumours are determined largely by the tissue of origin: mixed carcin-
omas with squamous and columnar components are found in the cervico-vaginal
epithelium only, basal cell carcinomas arise mainly from the hair follicles of the
vulva, sarcomas in the connective tissue. Squamous-celled tumours with varying
degrees of keratinization occur both in the vulval region and the cervico-vaginal
tract. Since no mixed carcinomas have been elicited inthe cervix and no primary
sarcomas in the vulva, the discussion deals mainly with the effect ofcastration and
__a
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dosage variation on the induction of comparable squamous-celled tumours in the
vulva and the cervico-vaginal tract and of sarcomas at the latter site. Basal-
celled tumours ofthe vulva are not considered here.
The process of carcinogenesis of the epithelial tumours is essentially the same
in the vulva and the cervico-vaginal region, passing from hyperplasia through
radication, papillomas, microcarcinomas to the fully malignant state. The
tumours are multifocal in origin and large " units " arise from the confluence of
adjacent foci. Penetration of the panniculus carnosus has been abandoned as
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FIG. 21.-Age-specific rates of induction by 40, 20, 10 or 5 weekly applications of DMBA of
squamous-celled vulval tumours in intact rats.
the criterion of malignancy, since hair follicles in anagen may pass through it and
since the cytological features of malignant tumours above and below this layer
are identical. Similarly invasion is considered an important step in malignant
progression, but is not as significant as the ability for continued proliferation of
invading cells. Invading cells which keratinize in the stroma as they do in the
microcarcinomatous stage, are not fully malignant and lack the quality of
"xxenoplasia ". This itself has various degrees in further progression as shown
for instance by the discrepancy between the incidence of lymphatic and vascular
permeation and embolism and that of metastatic deposits in regional nodes or at
distant sites. This means that tumour cells capable of growing in the adjacent
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stroma and ofinvading vessels may not yet be able to grow in other environments,
such as lymph nodes, lung, liver, etc.
Similar degrees in xenoplasia characterize the progression also of sarcomas
which may extend widely by continuous growth, invade vessels and lymphatics
and still produce metastatic deposits only relatively rarely. Whether sarcomas
have a multifocal or at least multicellular origin like the epithelial tumours,
cannot be proved. The early stages in their development are difficult to recognize
and evaluate and the well-defined intermediate steps in the formation of carcin-
omas, i.e. radication, papillomas and microcarcinomas are missing. Continued
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FiG. 22. Age-specific rates of induction by 40, 20, 10 or 5 weekly applications of DMBA of
squamous-celled vulval tumours in castrate rats.
proliferative activity with characteristic cytology and histology are the main
criteria for the diagnosis of their malignancy with later on invasion of extra-
territorial regions. The wide spectrum ofhistological features in a given sarcoma
may be interpreted as evidence for multicellular origin with subsequent fusion or
equally for the separation of different cell strains and clones from a single
" multipotential " malignant cell. Neither castration nor variation in frequency
of DMBA paintings appears to influence the histological type of sarcoma. The
influence of varying the number of paintings on the induction of tumours in the
cervico-vaginal tract and vulva can be seen in (a) the level of the threshold dose,
(b) the increase in tumour incidence and shortening of the induction period with
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increasing number of doses, (c) the levelling off of tumour induction at certain
dose levels, and (d) the appearance ofan " optimal
"dose, i.e. a decrease in tumour
incidence from a peak level with increasing number of paintings.
The threshold dose for induction of sarcomas is relatively high (Fig. 11), low
for epithelial tumours in cervix and vagina particularly of castrates (Fig. 14)
and intermediate for those of intacts and in the vulva (Table II). Thus the
sensitivity to the carcinogen is low for the cervico-vaginal stroma, intermediate
for the vulval epidermis and high for the cervico-vaginal epithelium of castrates.
The differences between intact and spayed rats suggest that hormonal influences
affect the sensitivity which is thus not a fixed property of the tissues.
The increase in tumour incidence and shortening of the induction period with
increased number of applications is shown in the incidence of sarcomas in intacts
(Fig. 12 and 13) and up to 20 applications in castrates; it is also evident in the
induction of vulval tumours (Fig. 19, 20, 21 and 22) and particularly for that of
carcinomas (TableII). Though this correlation is by no means linear, increases
in carcinogenic stimuli might be expected to increase the chances of malignant
conversion in a given tissue by either acting as initiators plus promoters on single
cells or by affecting a greater number of cells as must be the case in the multi-
focalorigins ofepithelial tumours. This correlation doesnotapplytoall neoplasms
and may hold only for certain ranges of dosage.
Thus for the induction ofsarcomas in spayed rats there is a significant increase
with dose up to 20 applications, but beyond this number there is, if anything, a
fall in incidence (Fig.11) and aslowing down in the rate oftumour induction (Fig.
12 and 13). Prolonging and increasing the number of applications during the
lifetime of the rats, i.e. for up to 58 weeks, fails to raise significantly the incidence
oftumours (Fig. 13). Sarcomas do not occur after an intervalof400 days (Fig. 12);
this may imply that after a certain period resistance to carcinogenic stimulation
supervenes under certain hormonal or environmental conditions, i.e. unless initi-
ated cells have formed a tumour by a certain time they are later unable to do so.
Such age-specific tumour incidences are known both for human pathology and for
induced tumours (Doll, 1962; Lindop and Rotblat, 1962). An acquired tolerance
for resistance to prolonged carcinogenic stimuli may account also for the levelling
off in sarcoma induction in castrates.
Except for rats given 2 injections of oestradiol within 48 hours of birth and
painted onceweekly with acetone, noepithelial cervico-vaginal tumours have been
observed in our strain of rats without the application of carcinogens (Cherry and
Glucksmann, 1968). It can thus be assumed that at least one application of
DMBA is required to induce such tumours though their percentage is not known.
With 5 doses some 70% occur in castrates and about 20% in intacts. This level
is maintained up to 20 doses but drops drastically with further applications
particularly in spayed animals (Fig. 14-16). This fall cannot be accounted for
by an increase in the incidence of sarcomas, since it increases in intact but not in
castrate animals. Furthermore, the rate of induction of epithelial tumours and
sarcomas up to 400 days is the same in castrates given 20 doses. There is thus
no interference or competition for the development of these two tumour types.
The incidence and rate of induction of vulval tumours shows no correlation with
that of cervico-vaginal neoplasms and no interference with them. While the
yield of papillomas and carcinomas in the cervix and vagina decreases with
increased dosage, that in the vulva increases with greater number of applications.
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The " optimal " dosage for the epithelial tumours ofthe cervix and vagina cannot
be accounted for either by competition with carcinogenesis elsewhere, or by any
shortening of the period of observation: the age-specific plots (Fig. 16) show that
for the same time interval castrates given 20 doses have 4 times the percentage
of tumours as those with 40 or more paintings. In intact rats fewer epithelial
tumours are induced at low dose levels and the reduction in incidence by increased
numbers of paintings is consequently not as drastic as in castrates.
Optimal dosages have been described for radiation induced tumours and one
ofthe hypotheses put forward in explanation is that at high dose levels a " lethal "
interferes with a " carcinogenic " action. This assumes that cells which might
have given rise to cancers are killed by larger doses of radiation and thus the
incidence of tumours decreases with increasing dose beyond a critical optimal
value. There is no evidence for an increased lethal effect with dosage or rather
number of applications of DMBA in the cervico-vaginal epithelium nor for any
increase in " carcinogenic " potency in the range of 5 to 20 applications. If a
lethal effect is assumed, it must affect potential stem cells for tumours selectively
since there is no widespread ulceration or degeneration of the epithelium. In
fact in castrate as well as in intact rats treated throughout life the cervico-vaginal
epithelium is hypertrophic and often shows radication as evidence ofproliferative
activity. Furthermore, the presumed effect would apply to the cervico-vaginal
epithelium and not to the vulval where the incidence of similar squamous-celled
tumours increases with number of paintings.
The decreased incidence of epitheliomas with increased number of treatments
might be explained by an inhibitory effect on the epithelium by the stroma
changed by DMBA. Though this explanation cannot be excluded categorically,
it is unlikely because in the castrate the stroma remains atrophic, while in the
intact it is often increased and stimulated to sarcoma formation. Also in castrates
treated intermittently with oestradiol or continuously with cholesterol and given
the same regime of DMBA, the stroma remains atrophic though the incidence of
epithelial tumours is greatly increased (Glucksmann and Cherry, 1968). It thus
seems likely that the inhibitory effect of increased dosage is exerted directly on
the cervico-vaginal epithelium, that it is concerned with the sensitivity to carcino-
gens and can be altered at least in castrates by additional treatments. The
exact mechanism of this action remains to be elucidated.
Castration generally promotes the appearance of cervico-vaginal papillomas
and carcinomas and inhibits that of sarcomas, though this statement has to be
qualified to allow for variation with dosage of carcinogens. Thus at low levels of
DMBA applications the threshold dose for sarcomas in castrates tends to be lower
than in intacts and the rate of tumour induction is also faster. At the high dose
level, however, the induction ofsarcomas is depressed both in rate and percentage
(Fig. 11 and 12). Again except for the highest dose level, the rate of induction
and total incidence of epithelial tumours of the cervix and vagina is significantly
increased in castrates (Fig. 14, 15 and 16). Though there is no apparent effect
of castration on the total incidence of squamous-celled tumours of the vulva
(Fig. 19-22), the progression to carcinomas occurs at lower dose levels in castrates
(Table II). Indiscussingthe effectsofcastrationoralternatively that ofadditional
oestrogenic medication on tumorigenesis it is essential to take into account the
level of carcinogenic stimulation. While allowance must be made for species
differences, reports of lower threshold levels for cervico-vaginal carcinomas in
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spayed mice (Murphy, 1961; Taki, 1967) and promotion of tumour formation by
oestrogens in castrates treated for limited periods with carcinogens may be cited
as evidence of the interdependence of carcinogenic dosage and hormonal status
and stimulation of the target organs. It is also necessary to draw attention to
the difference in structure of the target organ ifpainting rather than the impreg-
nated thread method is used: in the former the vagina and exocervix are the
principal targets, in the latter the endocervical region. While in the rat only
intermittent oestrogenic stimulation promotes the induction of cervico-vaginal
sarcomas and epitheliomas in castrates painted with DMBA throughout life, no
such effect occurs in intacts. Whether a similar promotion can be obtained by
continuous or intermittent oestrogenic stimulation at lower carcinogenic dose
levels is being investigated now.
The authors are grateful to Dame Honor B. Fell, F.R.S., for reading the manu-
script and to Mr. G. C. Lenney, A.I.S.T., for the illustrations.
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